Design Therapeutics, Inc. DSGN Non Cash Lease Expense Income
Non Cash Lease Expense Income at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept dsgn:NonCashLeaseExpenseIncome.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s non cash lease expense income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s non cash lease expense income?
- Design Therapeutics, Inc. (DSGN) reported non cash lease expense income of $69K in Q1 2026.
- How has Design Therapeutics, Inc.'s non cash lease expense income changed year-over-year?
- Design Therapeutics, Inc.'s non cash lease expense income increased by 1825.0% year-over-year, from -$4K to $69K.
- What does non cash lease expense income mean?
- This metric captures the non-cash portion of lease expenses or income recognized under accounting standards, such as the amortization of right-of-use assets or the unwinding of lease liabilities. It is added back to or subtracted from net income to reconcile to net cash provided by operating activities. Analyzing this helps investors isolate the actual cash impact of lease obligations from accounting-driven expense recognition.